RDY financials
Dr. Reddy's Laboratories (RDY) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RDY income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 | $353.47B | $186.52B | $48.87B | $45.09B | 53.92 |
| 2025 | $325.54B | $190.43B | $71.84B | $56.54B | 67.77 |
| 2024 | $279.16B | $163.61B | $67.73B | $55.68B | 66.80 |
| 2023 | $245.88B | $139.34B | $57.14B | $45.07B | 54.17 |
| 2022 | $214.39B | $113.84B | $29.48B | $23.57B | 28.34 |
| 2021 | $2.56B | $1.30B | $431.44M | $232.21M | 20.73 |
- RDY revenue was $353.47B in fiscal 2026, net income $45.09B.
Updated 2026-11-02 23:14 UTC